Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2026-05-26 @ 11:46 AM
Study NCT ID:
NCT00717405
Status:
COMPLETED
Last Update Posted:
2016-08-02
First Post:
2008-07-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords: